# US 2019/0316128 A1 · DELIVERY OF dsRNA TO ARTHROPODS

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316128 A1
- Document ID: US20190316128A1
- Status: Published application
- Kind: A1
- Application number: 16/436,183
- Filed: 2019-06-10
- Published: 2019-10-17
- Earliest claimed: 2001-07-06
- Assignees: Commonwealth Scientific and Industrial Research Organisation
- Applicants: Commonwealth Scientific and Industrial Research Organisation
- Inventors: Steven Whyard; Fiona Helen Cameron; Minoo Moghaddam; Trevor J. Lockett
- Web page: https://patentgrep.com/patent/US20190316128A1

## CPC

- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- A01K 67/65: Genetically modified arthropods
- A01N 57/16: containing heterocyclic radicals
- A61K 31/713: Double-stranded nucleic acids or oligonucleotides
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/04: Antibacterial agents
- A61P 31/12: Antivirals
- A61P 33/00: Antiparasitic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12N 15/1137: {against enzymes (viral enzymes C12N15/1131; receptors C12N15/1138)}
- C12Y 302/01031: Beta-glucuronidase (3.2.1.31)
- A01K 2217/05: Animals comprising random inserted nucleic acids (transgenic)
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C12N 2310/14: interfering nucleic acids [NA]
- C12N 2320/32: Special delivery means, e.g. tissue-specific
- C12N 2320/50: Methods for regulating/modulating their activity
- Y02A 40/146: Genetically Modified [GMO] plants, e.g. transgenic plants
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Y: ENZYMES
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The invention is to methods of gene silencing in arthropods using dsRNA. The method is include contacting the arthropod with, and/or directly feeding the arthropod, the dsRNA to the arthropods to deliver the dsRNA to arthropod tissues. It is envisaged that the methods of the invention will have use in determining the biological function of genes in arthropods. Methods of pest control of arthropods, and of protecting arthropods against parasites and predators are provided. Transgenic arthropods expressing dsRNA molecules are also provided by the present invention.

## Claims

### Claim 1

A method of determining the biological function of a target RNA in an arthropod comprising delivering to the arthropod a dsRNA molecule which specifically reduces the level of the target RNA and/or the production of a protein encoded by the target RNA in a cell of the arthropod, and assessing the effect of the dsRNA on at least one biological function of the arthropod.

### Claim 2 (depends on 1)

The method of claim 1, wherein the dsRNA is delivered by a process comprising contacting the arthropod with the dsRNA.

### Claim 3 (depends on 2)

The method of claim 2, wherein said contacting comprises wholly or partially soaking the arthropod in a composition comprising the dsRNA.

### Claim 4 (depends on 1)

The method of claim 1, wherein the dsRNA is delivered by a process comprising feeding the dsRNA to the arthropod.

### Claim 5 (depends on 1, 2, 3, 4)

The method according to any one of claims 1 to 4, wherein the dsRNA is delivered in a composition comprising a transfection promoting agent.

### Claim 6 (depends on 5)

The method of claim 5, wherein the transfection promoting agent is a lipid-containing compound.

### Claim 7 (depends on 6)

The method of claim 6, wherein the lipid-containing compound is selected from the group consisting of; Lipofectamine, Cellfectin, DMRIE-C, DOTAP and Lipofectin.

### Claim 8 (depends on 6)

The method of claim 6, wherein the lipid-containing compound is a Tris cationic lipid.

### Claim 9 (depends on 8)

The method of claim 8, wherein the Tris cationic lipid is selected from the group consisting of: CS096, CS102, CS129, CS078, CS051, CS027, CS041, CS042, CS060, CS039, and CS015.

### Claim 10 (depends on 5, 6, 7, 8, 9)

The method according to any one of claims 5 to 9, wherein the composition further comprises a nucleic acid condensing agent.

### Claim 11 (depends on 10)

The method of claim 10, wherein the nucleic acid condensing agent is selected from the group consisting of spermidine and protamine sulfate.

### Claim 12 (depends on 1)

The method of claim 1, wherein the dsRNA is delivered by a process comprising feeding a transgenic organism expressing the dsRNA to the arthropod.

### Claim 13 (depends on 12)

The method of claim 12, wherein the transgenic organism is a transgenic plant.

### Claim 14 (depends on 1)

The method of claim 1, wherein the dsRNA is delivered by a process comprising contacting the arthropod with a virus expressing the dsRNA.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The method according to any one of claims 1 to 14, wherein the dsRNA comprises a nucleotide sequence having at least 90% identity to at least a portion of the sequence of the target RNA.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The method according to any one of claims 1 to 14, wherein the dsRNA comprises a nucleotide sequence having at least 99% identity to at least a portion of the sequence of the target RNA.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The method according to any one of claims 1 to 16, wherein the arthropod is an insect.

### Claim 18

A composition comprising dsRNA and a transfection promoting agent, wherein said dsRNA comprises a nucleotide sequence that it is at least 90% identical to the sequence of a target RNA, wherein the target RNA is selected from the group consisting oft a naturally-occurring arthropod RNA, a naturally-occurring RNA of an organism that is a pathogen carried by an arthropod, a naturally-occurring RNA of a virus that infects an arthropod, an RNA copy of a naturally-occurring DNA virus that infects an arthropod, and a naturally-occurring RNA of a bacterium that infects an arthropod.

### Claim 19 (depends on 18)

The composition of claim 18, wherein the transfection promoting agent is a lipid-containing compound.

### Claim 20 (depends on 19)

The composition of claim 19, wherein the lipid-containing compound is selected from the group consisting of; Lipofectamine, Cellfectin, DMRIE-C, DOTAP and Lipofectin.

### Claim 21 (depends on 19)

The composition of claim 19, wherein the lipid-containing compound is a Tris cationic lipid.

### Claim 22 (depends on 21)

The composition of claim 21, wherein the Tris cationic lipid is selected from the group consisting of: CS096, CS102, CS129, CS078, CS051, CS027, CS041, CS042, CS060, CS039, and C8015.

### Claim 23 (depends on 18, 19, 20, 21, 22)

The composition according to any one of claims 18 to 22, wherein the composition further comprises a nucleic acid condensing agent.

### Claim 24 (depends on 23)

The composition of claim 23, wherein the nucleic acid condensing agent is selected from the group consisting of: spermidine and protamine sulfate.

### Claim 25 (depends on 18, 19, 20, 21, 22, 23, 24)

The composition according to any one of claims 18 to 24, wherein the composition is formulated such that it can be applied to an area inhabited by a population of arthropods.

### Claim 26 (depends on 18, 19, 20, 21, 22, 23, 24, 25)

The composition according to any one of claims 18 to 25, wherein the composition further comprises an agriculturally acceptable carrier.

### Claim 27 (depends on 18, 19, 20, 21, 22, 23, 24, 25, 26)

The composition according to any one of claims 18 to 26, wherein the composition is formulated as a bait.

### Claim 28

A method of controlling an arthropod pest comprising delivering to the arthropod dsRNA by a process comprising contacting the arthropod with said dsRNA or feeding said dsRNA to the arthropod, for a time and under conditions sufficient for said dsRNA, or a degradation product thereof, to specifically reduce the level of a target RNA and/or the production of a protein encoded by the target RNA in a cell of the arthropod, wherein the target RNA or the protein is important for arthropod survival, development and/or reproduction.

### Claim 29 (depends on 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The method of claim 28, wherein the dsRNA is delivered in a composition according to any one of claims 18 to 27.

### Claim 30

A method for controlling a pathogen transmitted by an arthropod, the method comprising delivering to the arthropod dsRNA by a process comprising contacting the arthropod with said dsRNA or feeding said dsRNA to said arthropod, for a time and under conditions sufficient for said dsRNA, or a degradation product thereof, to specifically reduce the level of a target RNA and/or the production of a protein encoded by the target RNA in a cell of the pathogen, wherein the target RNA or the protein is important for pathogen survival, development and/or reproduction.

### Claim 31 (depends on 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 30)

The method of claim 30, wherein the dsRNA is delivered in a composition according to any one of claims 18 to 27.

### Claim 32 (depends on 30, 31)

The method of claim 30 or claim 31, wherein the pathogen is selected from the group consisting of: fungi, protozoans, bacteria and viruses.

### Claim 33

A method of protecting an arthropod against a pathogen, parasite or predatory organism, the method comprising delivering to the arthropod dsRNA by a process comprising contacting the arthropod with said dsRNA or feeding said dsRNA to said arthropod, for a time and under conditions sufficient for said dsRNA, or a degradation product thereof, to so specifically reduce the level of a target RNA and/or the production of a protein encoded by the target RNA in a cell of the pathogen, parasite or predatory organism, wherein the target RNA or the protein is important for the survival, development and/or reproduction of the pathogen, parasite or predatory organism.

### Claim 34 (depends on 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 33)

The method of claim 33, wherein the dsRNA is delivered in a composition according to any one of claims 18 to 27.

### Claim 35

A transgenic organism comprising a heterologous nucleic acid(s) which is transcribed to produce a dsRNA, wherein the portion of the dsRNA which is double stranded is about 21 to about 50 base pairs in length.

### Claim 36 (depends on 35)

The transgenic organism of claim 35, wherein the dsRNA comprises a nucleotide sequence having at least 90% identity to at least a portion of the sequence of a target RNA selected from the group consisting of a naturally-occurring arthropod RNA, a naturally-occurring RNA of an organism that is a pathogen carried by an arthropod, a naturally-occurring RNA of a virus that infects an arthropod, an RNA copy of a naturally-occurring DNA virus that infects an arthropod, and a naturally-occurring RNA of a bacterium that infects an arthropod.

### Claim 37 (depends on 35, 36)

The transgenic organism of claim 35 or claim 36, wherein the portion of the dsRNA which is double stranded is about 21 to about 23 base pairs in length.

### Claim 38 (depends on 35, 36, 37)

The transgenic organism according to any one of claims 35 to 37, wherein the organism is selected from the group consisting of: plants and arthropods.
